Clinical trial
Double Blind-randomized Study Comparing the Efficacy of Two Analgesia (Ixprim® and Dafalgan-Codeine®) , in the Emergency Unit.
NCT01782846 is registered in ClinicalTrials.gov with Hopital Foch as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double Blind-randomized Study Comparing the Efficacy of Two Analgesia (Ixprim® and Dafalgan-Codeine®) , in the Emergency Unit.
- Lead sponsor
- Hopital Foch
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2011
- Completion date
- April 30, 2013
- Enrollment
- 803 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.